Phathom Pharmaceuticals I... (PHAT)
undefined
undefined%
At close: undefined
7.89
0.25%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 682.00K - - - - -
Cost of Revenue 167.00K 620.00K 521.00K 300.00K 8.00K -
Gross Profit 515.00K -620.00K -521.00K -300.00K -8.00K -
Operating Income -167.31M -172.44M -135.08M -125.67M -106.22M -1.23M
Interest Income 7.88M 2.13M 41.00K 1.09M 1.09M -
Pretax Income -201.59M -197.72M -143.88M -129.07M -255.13M -1.29M
Net Income -201.59M -223.01M -148.09M -133.32M -209.74M -1.29M
Selling & General & Admin 117.93M 101.00M 62.74M 27.52M 6.94M 1.21M
Research & Development 49.90M 71.44M 72.34M 98.15M 99.27M 20.00K
Other Expenses - -110.00K -2.06M -8.00K -49.56M -50.00K
Operating Expenses 167.83M 172.44M 135.08M 125.67M 106.22M 1.23M
Interest Expense 41.97M 27.30M 6.79M 4.58M 4.18M 13.00K
Selling & Marketing Expenses - - - - - -
Cost & Expenses 167.99M 172.44M 135.08M 125.67M 106.22M 1.23M
Income Tax - 25.28M 4.21M 4.25M -45.39M 13.00K
Shares Outstanding (Basic) 51.29M 39.12M 37.00M 33.23M 24.73M 8.58M
Shares Outstanding (Diluted) 51.29M 39.12M 37.00M 33.23M 24.73M 8.58M
EPS (Basic) -3.93 -5.7 -4 -4.01 -8.48 -0.15
EPS (Diluted) -3.93 -5.7 -4 -4.01 -8.48 -0.15
EBITDA -159.05M -171.82M -134.56M -124.19M -250.95M -50.00K
Depreciation & Amortization 575.00K 620.00K 521.00K 300.00K 8.00K 1.23M